Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's Disease

Aggregator

05 Nov 2026 0 comments

CONCLUSION: Skin αSyn-SAA detects pathological α-synuclein in living patients with high accuracy and distinguishes MSA from PD based on assay kinetics and fibril strain properties, supporting its potential as a biomarker to distinguish among synucleinopathies. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.